Crude oil and gasoline prices advanced on Friday, supported by persistent geopolitical risks in the Middle East and ongoing supply constraints, though gains were tempered by a stronger dollar and diplomatic signals.
CEO Brian Niccol says employees' questions about share prices reflect pride and care, as the coffee giant navigates workplace reforms and ongoing labor disputes.
Despite significant operational downtime from recent hurricanes, Cavco Industries reports a 12.3% year-over-year revenue increase to $507.5 million for Q2 FY2025, driven by a 15.7% jump in homes shipped. The company remains optimistic on market recovery and announces an additional $100 million share repurchase authorization.
Gold and silver prices retreated sharply from record highs as President Trump's nomination of Kevin Warsh to lead the Federal Reserve eased concerns over central bank independence, triggering a broad profit-taking sell-off.
Barrick Mining Corporation's stock fell nearly 10% Friday, mirroring a sharp drop in gold prices after President Trump's nomination of a mainstream candidate to lead the Federal Reserve calmed market anxieties about runaway inflation.
A growing financial strategy known as 'soft switching'—opening new bank accounts without closing old ones—is gaining traction. Experts say it can unlock higher yields, better features, and greater flexibility, but requires careful management to avoid pitfalls.
Bitcoin's sharp decline this week mirrors a wider market rout, with analysts pointing to a confluence of geopolitical tensions, policy fears, and tech sector volatility as key drivers. The sell-off raises fresh questions about near-term support levels for the flagship cryptocurrency.
Independent Bank Corporation (NASDAQ: IBCP) announces a dividend increase to $0.28 per share, continuing its decade-long track record of shareholder returns. Analysts highlight the payout's sustainability amid solid earnings growth projections.
Shares of the staffing leader surged after its Q4 earnings hinted at a potential end to a multi-year slump, with management pointing to positive sequential growth for the first time since 2021.
With Bitcoin consolidating below $90,000, a significant retreat from its October highs, investors are weighing whether this is a strategic entry point or a warning sign. We examine the competing narratives shaping the market's next move.
Pharmaceutical leader Eli Lilly will build a new manufacturing facility in Lehigh County, marking the largest life sciences investment in Pennsylvania history and bolstering U.S. production of next-generation weight-loss drugs.
Despite a major new Bitcoin purchase, MicroStrategy's stock has plunged to its lowest level since September 2024, as market turbulence and mixed analyst sentiment pressure the crypto-focused software firm ahead of its earnings report.
While retirement planning often focuses on savings, a critical financial metric—net worth—reveals a more precarious reality for many households. We examine the causes and consequences of negative net worth, offering actionable steps to build a stronger financial foundation.
From a $10 direct listing to a $150 S&P 500 constituent, Palantir's journey has been fueled by the AI boom. As government and commercial demand surge, analysts project staggering growth. But with sky-high valuations, the path forward requires navigating lofty expectations.
Popular, Inc. (BPOP) shares have rallied following robust 2025 results, driven by higher net interest income, EPS growth, and aggressive shareholder returns via dividends and buybacks. With the stock up nearly 20% in 90 days, investors are weighing whether its current valuation still offers an entry point.
Insulet (PODD) shares have faced significant pressure in recent months, diverging from the company's underlying business performance. This analysis delves into whether the current price weakness presents a buying opportunity for the Omnipod maker or reflects deeper market concerns about its premium valuation and growth sustainability.
The FDA has cleared Intuitive Surgical's da Vinci 5 robotic system for select complex cardiac procedures, a move that could reshape the landscape of minimally invasive heart surgery and open a significant new market for the industry leader.
French biopharma firm Inventiva (ENXTPA:IVA) has delivered a stunning 126% total return to shareholders over the past year, sharply contrasting with losses over a three-year horizon. As the stock experiences short-term pullbacks, analysts debate whether its current €5.23 price reflects future promise or present hype, with a key drug candidate hanging in the balance.
New unemployment filings in Wisconsin edged higher last week, contrasting with a slight national decline and highlighting regional economic disparities as labor market signals remain mixed.
Missouri's inaugural month of legal sports betting attracted over $540 million in wagers, but aggressive promotions led to a net revenue loss for operators, even as the state collected millions in fees and taxes.
